Cardiac Rehabilitation Program in Patients with Cardiovascular Disease
Impact of a Cardiac Rehabilitation Program in Patients with Cardiovascular Disease
1 other identifier
interventional
80
1 country
1
Brief Summary
This protocol study aims to evaluate the effectiveness of a cardiac rehabilitation intervention program in patients with cardiovascular diseases to improve both anthropometric and biochemical data, as well as other variables related to cardiovascular disorders (cardiorespiratory fitness, muscle strength, …), and emotional aspects (anxiety, depression). Additionally, this study aims to evaluate the effectiveness of the cardiac rehabilitation program in improving body composition (waist circumference and body fat percentage), blood pressure and health-related quality of life. Objectives: i) To assess the functional capacity of patients with a recent cardiovascular event (acute coronary syndrome, onset heart failure, valve or bypass surgery) or with chronic decompensated cardiovascular disease (valvulopathy, pulmonary hypertension, congenital heart disease, heart failure) chronic), ii) to determine the different cardiorespiratory parameters obtained from cardiopulmonary exercise testing (CPET), iii) to determine the lifestyle habits and cardiovascular risk factors, iv) to develop a cardiac rehabilitation program according to and adapted to the need of each of these patients, v) to estimate the effect of the intervention, both in the muscle strength and in post-intervention CPET, biochemical and anthropometric parameters, v) to estimate the effect of the intervention in the quality of life, anxiety, depression, and adherence to the Mediterranean diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cardiovascular-diseases
Started Jul 2024
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedStudy Start
First participant enrolled
July 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedSeptember 19, 2024
September 1, 2024
20 days
January 8, 2024
September 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in peak oxygen uptake
Cardiopulmonary exercise test (CPET)
Baseline and at the end of the 8weeks intervention
Change in cardiorespiratory fitness
6 minutes walking test (6MWT)
Baseline and at the end of the 8weeks intervention
Secondary Outcomes (39)
Change in blood pressure
Baseline and at the end of the 8weeks intervention
Change in basal heart rate
Baseline and at the end of the 8weeks intervention
Change in Maximum heart rate:
Baseline and at the end of the 8weeks intervention
Change in oxygen consumption efficiency slope (OUES)
Baseline and at the end of the 8weeks intervention
Change in Respiratory gas exchange ratio (RER)
Baseline and at the end of the 8weeks intervention
- +34 more secondary outcomes
Study Arms (1)
Intervention
EXPERIMENTALParticipants will be included in a cardiac rehabilitation program.
Interventions
Physical exercise intervention within a cardiac rehabilitation program, lasting 2 months, 3 days per week. The intervention consists of a first part of warm up the large muscle groups, accompanied by breathing exercises, followed by a part of strength and muscular resistance training exercises (upper and lower limbs and abdominal muscles), another part of aerobic exercise part (continuous and interval), using a treadmill or cycle ergometer, and finally a part of stretching exercises and a cool-down phase.
Eligibility Criteria
You may qualify if:
- Patients aged between 20 and 80 years
- Having suffered an acute event or presenting chronic cardiovascular pathology with a decrease/limitation of their functional capacity
- Residing in the provinces of Cuenca, Toledo, or Albacete
- Desire to participate voluntarily and acceptance of the conditions
You may not qualify if:
- Have some physical or mental pathology that prevents their participation
- Inability to adhere to the full program as reported in the initial consultation
- Being outside the age criteria defined above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Castilla-La Manchalead
- Hospital Virgen de la Luzcollaborator
Study Sites (1)
Hospital Virgen de la Luz
Cuenca, Cuenca, 16002, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susana Priego-Jiménez, MsC
Hospital Virgen de la Luz
- PRINCIPAL INVESTIGATOR
Laura Núñez-Martínez, MsC
Hospital Virgen de la Luz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 8, 2024
First Posted
January 18, 2024
Study Start
July 10, 2024
Primary Completion
July 30, 2024
Study Completion
October 30, 2024
Last Updated
September 19, 2024
Record last verified: 2024-09